SSRIs have been shown to inhibit reuptake of serotonin in platelets, ultimately impairing platelet aggregation.
Erica L. Wegrzyn, PharmD
Advertisement
Articles by Erica L. Wegrzyn, PharmD
Advertisement
Latest Updated Articles
Carefully Assess Bleeding Risk in Patients on AntidepressantsPublished: March 19th 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA, HHS Move to Accelerate Biosimilar Approvals
2
Accelerated Approval of Cancer Drugs: Benefit or Burden?
3
Pharmacists Lead the Way in Evolving CAR T-Cell and Bispecific Antibody Therapy Management
4
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
5
